Antitrypsin Deficiency

Apr 01, 2025

Sanofi’s Qfitlia Becomes First FDA-Approved Therapy for Hemophilia A or B; FDA Approves AstraZeneca’s IMFINZI as First Perioperative Immunotherapy for Bladder Cancer; Beam Therapeutics’ BEAM-302 for AATD Receives FDA Clearance; AstraZeneca’s CALQUENCE Combo Greenlit in EU for Mantle Cell Lymphoma; Ionis’ WAINZUA Wins EU Approval for Hereditary Transthyretin Amyloidosis

May 15, 2019

Antitrypsin Deficiency Pipeline

May 13, 2019

Unmet Needs in the treatment of Antitrypsin deficiency

Newsletter/Whitepaper